Lilly Supports Direct Relief’s Efforts To Expand Access to Medicines by Improving Cold Chain Capacity
INDIANAPOLIS, IN and SANTA BARBARA, CA / ACCESSWIRE / January 26, 2023 / Direct Relief:Eli Lilly and Company (NYSE:LLY) and Direct Relief today announced a new initiative to expand access to medicines in low- and middle-income countries by boosting …
INDIANAPOLIS, IN and SANTA BARBARA, CA / ACCESSWIRE / January 26, 2023 / Direct Relief:
Eli Lilly and Company (NYSE:LLY) and Direct Relief today announced a new initiative to expand access to medicines in low- and middle-income countries by boosting cold chain capacity in 17 countries. Supported by $1.15M in funding from Lilly, Direct Relief will purchase and install an estimated 150 medical-grade refrigeration units at 25 Life for a Child (LFAC) partner facilities in Africa, Latin America, the Caribbean and Southeast Asia.
Cold chain - the transportation and storage of temperature-controlled medications - is a vital component of medical logistics, especially as the global pharmaceutical industry shifts towards the production of biologics and other temperature-sensitive molecules. The World Health Organization's Global Diabetes Compact calls on the private sector to do more to support capacity building in supply chain management, including cold storage.
"We appreciate Direct Relief's extensive expertise in logistics and end-to-end supply chain management and know this effort will make a substantial difference in providing patients around the world with medicines they need to address serious health issues like diabetes," said Leigh Ann Pusey, executive vice president, corporate affairs and communications for Lilly. "Efforts to expand access to medicines, especially insulin, are only beneficial when effective cold chain systems are in place to keep them at the right temperature on their way to patients."
Lesen Sie auch
The manufacturing of insulin requires consistent refrigeration at between two and eight degrees Celsius. Lilly's support of Direct Relief's cold chain initiative is part of Lilly 30x30, an effort which aims to improve access and address barriers to quality healthcare for 30 million people living in limited-resource settings annually, by 2030. The initiative builds on decades of Lilly's global health work to improve equitable access to diabetes care and medicines. In 2022, Lilly and its affiliates provided insulin and reusable pens to Direct Relief related to support of the Life for a Child program, impacting more than 30 countries worldwide.